Lincoln Pharmaceuticals (NSE:LINCOLN) E10: ₹38.09 (As of Mar. 2026)


NSE:LINCOLN Lincoln Pharmaceuticals Ltd NSE:LINCOLN
81 GF Score
Price ₹622.10
GF Value ₹702.91
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lincoln Pharmaceuticals E10?

Lincoln Pharmaceuticals NSE:LINCOLN -0.22% 81 E10 is ₹38.09 as of Mar. 2026. GuruFocus rates NSE:LINCOLN with a GF Score™ of 81/100 and a GF Value™ of ₹702.91 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lincoln Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹5.810. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹38.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Lincoln Pharmaceuticals's average E10 Growth Rate was 10.40% per year. During the past 3 years, the average E10 Growth Rate was 13.20% per year. During the past 5 years, the average E10 Growth Rate was 15.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lincoln Pharmaceuticals was 17.80% per year. The lowest was 13.20% per year. And the median was 15.60% per year.

As of today (2026-07-02), Lincoln Pharmaceuticals's current stock price is ₹622.10. Lincoln Pharmaceuticals's E10 for the quarter that ended in Mar. 2026 was ₹38.09. Lincoln Pharmaceuticals's Shiller PE Ratio of today is 16.33.

During the past 13 years, the highest Shiller PE Ratio of Lincoln Pharmaceuticals was 27.78. The lowest was 11.50. And the median was 15.88.


Lincoln Pharmaceuticals  (NSE:LINCOLN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lincoln Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=622.10/38.09
=16.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lincoln Pharmaceuticals was 27.78. The lowest was 11.50. And the median was 15.88.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lincoln Pharmaceuticals E10 Related Terms


Lincoln Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Lincoln Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lincoln Pharmaceuticals E10 Chart

Lincoln Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.27 26.29 30.97 34.46 38.09

Lincoln Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.46 35.68 36.58 37.69 38.09

NSE:LINCOLN vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lincoln Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's Shiller PE Ratio falls into.


NSE:LINCOLN
81GF Score
Lincoln Pharmaceuticals Ltd NSE:LINCOLN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lincoln Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lincoln Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.81/164.2724*164.2724
=5.810

Current CPI (Mar. 2026) = 164.2724.

Lincoln Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201606 6.990 105.961 10.837
201609 5.420 105.961 8.403
201612 3.270 105.196 5.106
201703 0.500 105.196 0.781
201706 2.460 107.109 3.773
201709 5.650 109.021 8.513
201712 5.790 109.404 8.694
201803 3.410 109.786 5.102
201806 8.030 111.317 11.850
201809 7.500 115.142 10.700
201812 4.570 115.142 6.520
201903 4.250 118.202 5.906
201906 6.330 120.880 8.602
201909 9.460 123.175 12.616
201912 5.460 126.235 7.105
202003 4.470 124.705 5.888
202006 7.630 127.000 9.869
202009 10.460 130.118 13.206
202012 6.730 130.889 8.446
202103 6.290 131.771 7.841
202106 8.840 134.084 10.830
202109 11.500 135.847 13.906
202112 8.790 138.161 10.451
202203 5.510 138.822 6.520
202206 7.490 142.347 8.644
202209 11.840 144.661 13.445
202212 10.790 145.763 12.160
202303 6.280 146.865 7.024
202306 9.490 150.280 10.374
202309 13.810 151.492 14.975
202312 14.000 152.924 15.039
202403 9.280 153.035 9.961
202406 11.820 155.789 12.464
202409 13.150 157.882 13.682
202412 10.370 158.323 10.760
202503 5.780 157.552 6.027
202506 13.820 159.755 14.211
202509 9.980 162.289 10.102
202512 14.280 163.281 14.367
202603 5.810 164.272 5.810

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹38.09 mean?
Lincoln Pharmaceuticals (NSE:LINCOLN) has a E10 of ₹38.09 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lincoln Pharmaceuticals and its competitors.
Is Lincoln Pharmaceuticals' E10 too high?
Lincoln Pharmaceuticals' current E10 is ₹38.09. Overall, Lincoln Pharmaceuticals has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lincoln Pharmaceuticals' E10 compare to ZTS and UTHR?
Lincoln Pharmaceuticals' E10 of ₹38.09 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lincoln Pharmaceuticals and its competitors. Lincoln Pharmaceuticals's current E10 is ₹38.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lincoln Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lincoln Pharmaceuticals (NSE:LINCOLN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹702.91, compared to a current price of ₹622.10 — trading 11.5% below its estimated fair value. The current E10 is ₹38.09. Lincoln Pharmaceuticals' overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Lincoln Pharmaceuticals (NSE:LINCOLN), the current E10 is ₹38.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lincoln Pharmaceuticals (NSE:LINCOLN) Overvalued in 2026?

Based on GuruFocus' analysis, Lincoln Pharmaceuticals stock appears to be undervalued. The current stock price of ₹622.10 is trading 11.5% below its estimated GF Value™ of ₹702.91. GuruFocus considers Lincoln Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:LINCOLN:

  • E10: ₹38.09
  • GF Value™: ₹702.91 vs. price of ₹622.10 (11.5% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the NSE:LINCOLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lincoln Pharmaceuticals Business Description

Other Exchanges 531633:India
Address Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
81GF Score

Get the complete analysis for NSE:LINCOLN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹622.10
Price
₹702.91
GF Value